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Abstract
Apoptosis is a process that plays a critical role in the elimination of infected cells.
Infectious diseases modulate apoptosis, and this contributes to disease pathogene‐
sis. Apoptosis is initiated by various kinds of stimuli, including infections, radia‐
tion, etc. Increased apoptosis may assist the dissemination of intracellular
pathogens or induce immunosuppression. However, apoptosis may also help eradi‐
cate pathogens from the host in many cases. Consequently, several viruses, bacteria,
and parasites have evolved mechanisms to inhibit host cell by apoptosis as a strat‐
egy that may support intracellular survival and persistence of the pathogen. Bacte‐
ria are recognized by cellular receptors and elicit a multitude of signal transduction
events that alter the cell’s response toward apoptotic stimuli. The result of patho‐
genic bacteria entering into mammalian cells evokes variety of responses, including
internalization or phagocytosis of the bacteria, release of cytokines, secretion of de‐
fensins, production of oxygen radicals and the triggering of apoptosis. Bacteria can
trigger apoptosis through a large variety of mechanisms that include the secretion
of protein synthesis inhibitors and pore forming proteins. They can also activate
apoptotic proteins such as caspases, inactivate antiapoptotic proteins, or lead to up‐
regulation of the endogenous receptor/ligand system. However, new research has
shown that many bacterial pathogens can in fact prevent apoptosis during infection.
As in bacteria, many viral genomes encode proteins that repress apoptosis to escape
from immune attack by the host or viruses promote apoptotic death of the host
cells. Virus-host interactions may determine viral persistence, extent and severity of
inflammation, and pathology associated with infectious disease. The elucidation of
the signaling pathways, the cellular receptors, and/or the microbial factors involved
in the induction or reduction of apoptosis could reveal new therapeutic targets for
blocking microbial-induced apoptosis. This chapter will summarize the most recent
research on microorganisms’ apoptotic and antiapoptotic strategies and the mecha‐
nisms relating to disease.
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1. Introduction
1.1. Apoptosis regulators
Programmed cell death or apoptosis is an intrinsic death program that occurs in various
physiological and pathological situations. Apoptosis is also a physiological process that is
critical for tissue homeostasis. It is essential for the regulation of immune responses. The main
regulators of apoptosis are caspases, Bcl-2 family, p53, tumor necrosis factor (TNF) family,
and/or inhibitors of apoptosis proteins (IAPs).
2. Caspases
Caspases are a family of proteins that are one of the main effectors of apoptosis. Their activation
is a hallmark of apoptosis. Caspases are synthesized as inactive zymogens, the so-called
procaspases. Upon maturation, the procaspases are proteolytically processed between the
large and small subunit resulting in a small and a large subunit.
Based on their function, the caspases can be classified into three groups: (1) inflammatory
caspases—this group includes caspases 1, 4, 5, 11, 12, 13, and 14, which are involved in
inflammation instead of apoptosis; (2) apoptotic initiator caspases that possess long prodo‐
mains containing either a death effector domain (DED) (caspases 8 and 10) or a caspase
activation and recruitment domain (CARD) (caspases 2 and 9), which mediate the interaction
with upstream adaptor molecules; and (3) apoptotic effector caspases. This executioner class
(caspases 3, 6, 7) is characterized by the presence of a short prodomain [1]. Apoptotic signals
trigger the oligomerization of death adaptor proteins, while death adaptor oligomers in turn
induce the aggregation of procaspases. It was previously believed that the initiator caspases
are autoproteolytically activated when brought into close proximity of each other. This is called
the “induced proximity” model. Effector procaspases are normally cleaved and activated by
active initiator caspases. They then cleave various death substrates to induce cell death [2].
3. IAPs
The IAPs represent a family of evolutionarily conserved apoptosis suppressors. Although IAP
family proteins may possess other functions, several of them have been shown to bind and
potently inhibit activated caspases. Among the caspases inhibited by human IAP family
members, XIAP, cIAP1, and cIAP2 are the effector caspases 3 and 7 as well as the initiator
caspase 9 [3]. IAP expression can be upregulated in response to survival signals such as those
coming from growth factor receptors, e.g., by the activation of the transcription factor. Nuclear
factor-kappa B (NF-κB), however, provides a means to suppress apoptosis signaling. IAP
inhibitor SMAC/Diablo was recently described as those that bind multiple IAP family
members and those that allow caspases to induce apoptosis [4].
Cell Death - Autophagy, Apoptosis and Necrosis232
4. Bcl-2 family
The Bcl-2 family consists of both antiapoptotic and proapoptotic proteins that share sequence
homology within conserved regions known as Bcl-2 homology (BH) domains. All antiapop‐
totic members such as Bcl-2 and Bcl-XL and a subset of proapoptotic family members such as
Bax and Bak are multidomain proteins sharing sequence homology within three to four BH
domains [5].
5. p53
One of the most important p53 functions is its ability to activate apoptosis. The disruption of
this process can promote tumor progression and chemoresistance. p53 tumor suppressor
protein blocks cell cycle progression allowing time to repair the damage or induces apoptosis
largely through the upregulation of the Bcl-2 family BH3-only protein Puma (p53 upregulated
modulator of apoptosis). Many apoptosis-related genes that are transcriptionally regulated by
p53 have been identified. p53-dependent apoptosis is frequently the one induced following
DNA damage caused by irradiation, UV or viral infections. p53-independent pathways are
usually those resulting from growth factor deprivation. The activation of p53 by DNA damage
induces either cell cycle arrest or apoptosis. p53 mediates apoptosis through a linear pathway
that involves Bax transactivation, Bax translocation from the cytosol to membranes, cyto‐
chrome c release from mitochondria, and caspase 9 activation followed by the activation of
caspases 3, 6, and 7 [6,7].
5.1. Apoptosis signaling pathways
Apoptosis can be induced in response to various signals from inside and outside the cell.
Apoptosis process involves two pathways: (1) by the release of cytochrome c from mitochon‐
dria—intrinsic pathway and/or (2) by the activation of cell-surface death receptor—extrinsic
pathway [8].
5.2. Intrinsic pathway
Mitochondria is a central regulator of intrinsic apoptotic pathways. Intrinsic apoptotic
pathways are initiated inside cells. Numerous cytotoxic stimuli and proapoptotic signal-
transducing molecules converge on mitochondria to induce outer mitochondrial membrane
permeabilization. Mitochondria are known as an important intracellular organelle for pro‐
ducing energy. Mitochondria also play a key role in the modulation of Ca2+ homeostasis and
oxidative stress. The dysfunction of mitochondria induced by DNA damage or other genotoxic
factors leads to an irreversible event, apoptotic cell death. The intrinsic apoptotic pathway is
also called “mitochondrial pathway.” A pivotal event in the mitochondrial pathway is
mitochondrial outer membrane permeabilization (MOMP). MOMP is mainly mediated and
controlled by Bcl-2 family members [9]. Many proteins of the Bcl-2 family either with antia‐




outer membrane of the mitochondria. In healthy cells, a small proportion of Bak molecules are
bound to voltage-dependent anionic channel (VDAC; part of the [permeability transition]
[PT]). The antiapoptotic molecules Bcl-2 and BclXL prevent the translocation of cytochrome c
from the mitochondria, while the induced expression or enforced dimerization of Bax results
in dysfunction leading to cytochrome c release [10].
Specific stimuli such as oxidants, calcium overload, or ceramide cause a decrease in mito‐
chondrial inner transmembrane potential (∆Ψm) and result in the release of cytochrome c from
the mitrochondrion. Active Bax/Bak causes the release of cytochrome c, which then binds to
APAF-1 and causes its oligomerization. The release of cytochrome c from the mitochondrial
intermembrane space to the cytosol contributes to the formation of the apoptosome that
consists of cytochrome c, APAF-1, and dATP. Caspase 9 is recruited into the complex and
activated in this process. The apoptosome activates caspase 9, which is another initiator
caspase. Active caspase 9 cleaves and thereby activates effector caspases (most notably caspase
3), and active effector caspases cause the morphological signs of apoptosis by cleavage of other
effector proteins [11]. During apoptosis, cells undergo several morphological and biochemical
changes. Due to endonuclease activation, the chromatin is cleaved into oligonucleosomal
fragments. Recently, it was shown that structural changes in the plasma membrane of the
apoptotic cell are functional in signaling the process of cell death to the environment [12].
Active proteases, including caspases, calpains, cathepsins, and/or serine proteases, can
promote the activation of DNases in different ways. Effector caspases cleave and inactivate
DNA repair enzyme poly-ADP-ribose polymerase (PARP). Regulators of the cell cycle such as
retinoblastoma protein and structural proteins of the nucleus and cytoskeleton such as lamins,
growth arrest-specific protein 2, gelsolin, fodrin, and survival proteins such as protein kinase
C-δ (PKC-δ) cause cell death [13].
Caspase 3 is responsible for degradation of the nuclear protein PARP, which is involved
in DNA repair. Apoptosis inducing factor (AIF) is a proapoptotic factor in mitochondria.
It  triggers  chromatin  condensation  and  DNA  degradation  in  a  cell  in  order  to  induce
apoptosis [14].
5.3. Extrinsic pathway
The extrinsic pathway is activated by ligand-bound death receptors, mainly including (a) TNF-
TNFR1, (b) FasL-Fas, and (c) TNF-related apoptosis-inducing ligand (TRAIL) DR4 or DR5.
Death receptors belong to the tumor necrosis factor receptor gene (TNFR) superfamily and can
generally have several functions that include initiating apoptosis. The TNFR superfamily is
characterized by the presence of cysteine-rich domains that mediate binding between ligands
and these type I transmembrane domain receptors. Among them, the death receptors,
including TNF-R1, Fas (or CD95), and the TRAIL receptors DR4 and DR5, are best character‐
ized for induction of apoptosis [15].
5.3.1. TNF pathway
TNF is a multifunctional proinflammatory cytokine mainly produced by macrophages. There
are two major TNF receptors, TNF-R1 and TNF-R2. TNF-R1 is ubiquitously expressed in most
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tissues and is the major mediator of TNF signaling, whereas TNF-R2 is mainly found in the
immune system and only can be fully activated by membrane bound TNF [16].
TNF-induced activation of NF-κB, JNK, and apoptosis has been intensively studied. NF-κB is
a transcription factor that can be induced by a variety of signals. Inhibitor of КB (I-КB) binds
to NF-κB and inactivates it by localizing NF-κB to the cytosol, where it is unable to regulate
transcription. The phosphorylation of I-КB targets it for ubiquitination and degradation. In
the absence of I-КB, NF-κB’s nuclear localization signal is exposed, and NF-κB localizes to the
nucleus where it is able to induce transcription. The role of NF-κB was originally described as
a factor associated with apoptosis. This process is triggered by the phosphorylation of I-КB by
the I-КB kinase (IKK) complex. Different activation pathways of NF-κB may cause the
expression of proteins that promote apoptosis (e.g., Fas, c-myc, p53, TNF, DR, and caspase 11)
or inhibit apoptosis (e.g., IAP proteins, Bcl-2-like proteins) [17]. It was subsequently shown
that the inhibition of NF-κB activation potentiates apoptosis [18]. In addition, the inhibition of
I-КB expression by oligonucleotides led to cell transformation. Consistent with this role, NF-
κB has been shown to induce transcription of antiapoptotic proteins. Akt is reported to
phosphorylate and activate IKK. The activation of IKK causes phosphorylation and degrada‐
tion of I-КB, which leads to the localization of NF-κB to the nucleus where it can induce
transcription of antiapoptotic genes. Thus, Akt can inhibit apoptosis by activating NF-κB [19].
TNF also induces the activation of the stress-activated protein kinase (SAPK)/c-Jun N-terminal
kinase (JNK) pathway. Upon activation, JNK kinases translocate into the nucleus and enhance
the transcriptional activity of transcription factors, for example, c-Jun and activating tran‐
scription factor-2 by the phosphorylation of their amino-terminal activation domains. c-Jun
belongs to a group of basic region-leucine zipper proteins that dimerize to form transcription
factors commonly designated as activator protein 1 (AP-1). The AP-1 proteins have an
important role in a variety of cellular processes, including proliferation, differentiation, and
induction as well as prevention of apoptosis [20].
5.3.2. FAS pathway
Fas is involved in the cytotoxic T lymphocyte (CTL)-mediated killing of cells (e.g., CTL-
mediated killing of virus-infected cells), destruction of inflammatory and immune cells in
immune-privileged sites, and deletion of self-reacting B cells and activated T cells at the end
of an immune response [21]. Fas binding to Fas ligand results in intracellular clustering of
death domains (DD) followed by its internalization into an endosomal pathway. This allows
an adaptor protein called Fas-associated death domain (FADD) to associate with the receptor
through an interaction between homologous death domains on both molecules. FADD also
contains a DED that allows binding of procaspase 8 to the CD95-FADD complex. Procaspase
8 (also known as FLICE) associates with FADD through its own death effector domain. Caspase
8, the main initiator caspase in CD95 signaling, is expressed as two isoforms, caspases 8/a and
8/b, which are both recruited to the activated CD95 receptor. FasL-induced clustering of Fas,
FADD, and caspase 8 within the death-inducing signaling complex leads to autoproteolytic
processing of caspase 8 by induced proximity and dimerization followed by the release of the




ment for mitochondrial pathway in FAS-induced apoptosis. In type I cells, processed caspase
8 is sufficient to directly activate other members of the caspase family. In type II cells, the
efficient activation of effector caspases by Fas depends on an amplification loop that relies on
caspase-8-mediated cleavage of Bid and subsequent release of mitochondrial proapoptotic
factors such as SMAC/Diablo or cytochrome c to drive the formation of the caspase-9-activating
apoptosome. Active caspase 9 activates the executioner caspase 3, which in turn activates
caspase 8 [23].
5.3.3. TRAIL pathway
Like Fas, TRAIL may also be involved in the immune response and in tumor surveillance. Five
distinct TRAIL receptors have been identified: death receptor 4 (TRAIL-R1), 125 KILLER/DR5
(TRAIL-R2, TRICK2), DcR1 (TRID, TRAIL-R3), DcR2 (TRUNDD OR TRAIL-R4), and osteo‐
protegerin. The apoptotic signaling induced by TRAIL is similar to that induced by FAS.
Binding of TRAIL to its receptors DR4 or DR5 triggers the formation of a death-inducing
signaling complex by recruiting FADD and/or caspases 8 and/or 10. TRAIL-induced apoptosis
also involves the mitochondrial pathway, like Fas-induced apoptosis, in type II cells [24,25].
6. Apoptosis and bacterial infections
During a microbial infection, organism faces the challenge of recognizing and combating the
invading organism. The entrance of bacterial pathogens into human organism initiates the
innate immune response characterized by the recruitment of leukocytes to sites of infection
[26]. After phagocytosis by human macrophages, microorganisms are destroyed by reactive
oxygen species (ROS) microbicidal products contained within granules [27]. Otherwise,
bacterial pathogens that cause apoptosis target immune cells such as macrophages and
neutrophils [28]. Bacteria can trigger apoptosis by different mechanisms, including the
secretion of protein synthesis inhibitors, pore forming proteins, molecules activating the
endogenous death machinery in the infected cell, or lipopolysaccharides and other superan‐
tigens [29]. These molecules might be either proapoptotic and activated by the bacteria or
antiapoptotic and inhibited upon infection to trigger apoptotic death of the infected cell [30]
(Table 1).
Bacteria Apoptosis Proposed or demonstrated mechanism Cell type
Pseudomonas aeruginosa Induction Fas/Fas ligand system Endothelial cells
Cytochrome c release Epithelial cells
Neisseria gonorrhoeae Induction Increases mitochondrial permeability Epithelial cells
Inhibition Increases antiapoptotic genes PMLs
Epithelial cells
Neisseria meningitidis Inhibition Prevents cytochrome c release HeLa cells
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Shigella flexneri Induction Caspase 1 activation Macrophages
Inhibition Prevents cytochrome c release Epithelial cells
Shiga toxins Induction Extrinsic and intrinsic pathways Epithelial, endothelial,
neurons
myeloid and lymphoid cells
Salmonella typhimurium Induction Caspase 1 activation Macrophages
Inhibition PI3K-Akt/PKB-pathway Epithelial cells
Listeria monocytogenes Induction Cytochrome c release Hepatocytes, lymphocytes
dendritic cells
Chlamydia trachomatis Inhibition Prevents cytochrome c release Epithelial cells,
macrophages
Chlamydia pneumoniae Inhibition Bcl-2 HeLa cells
Raf/MEK/ERK survival pathway
Yersinia pseudotuberculosis Induction Inhibits ERK and the NFКB Macrophages, dendritic
cells
Yersinia enterocolitica TLR4
Yersinia pseudotuberculosis Inhibition Inhibits ROS production PMLs
Yersinia enterocolitica
Yersinia pestis Induction Caspase 1 activation Macrophages
Inhibits ERK and the NFКB
Legionella pneumophila Induction Caspase 3 Macrophages, epithelial
cells
Inhibition Up regulating of anti-apoptotic genes Monocyte, U937,A549 cells
NF-κB pathway
Escherichia coli K1 Induction Extrinsic and intrinsic pathways Epithelial cells
Inhibition Expression BclXL Macrophages
Rickettsia rickettsii Inhibition Activation of cell survival pathways Endothelial cells
Induction DNA fragmentation Neurons
Mycobacterium tuberculosis Induction TNF pathway Macrophages
Intrinsic pathway
Inhibition Activation of the NF-κB Epithelial cells
Expression of Bcl-2
Viruses Apoptosis Proposed or demonstrated mechanism Cell type





Inhibition Inhibits both Fas pathway and intrinsic
pathway
Hepatocytes
HIV-1 gp120 protein Induction Fas pathway CD4+ T cells
HIV-1 proteins Env Induction p53-dependent genes Puma and Bax
HIV Nef Induction Extrinsic pathway
Rabies virus Induction Expression of Bax and caspase 1 Neuroblastoma cell
Induction Caspase gene Nedd-2 Neurons
Activation of caspase 8
Upregulation of AIF
Epstein-Barr virus Inhibition Bcl-2 proteins, BHRF1, and BALF1 B cells
NF-κB pathway lymphoblastoid cell lines
Upregulation of antiapoptotic genes
Baculovirus Inhibition Antiapoptotic genes (p35 and IAP) Insect cells
HPV E2 protein Induction p53 pathway HeLa cells
HPV E6 protein Induction Degradation p53 pathway Epithelial cells
Induction Extrinsic pathway Cervical carcinoma cells
Inhibition Caspase inactivation fibroblasts, osteosarcoma
cells
HPV E7 protein Induction Retinoblastoma gene Lens
Adenoviral proteins
E1A Induction p53 pathway REF52 cells
E4orf4 Induction p53 pathway, caspase activation H1299, 293 cells
E4orf6 Induction PARP-induced cell death U251 cells
E1B-19K Inhibition Inhibits extrinsic pathway HeLa cells ,A549 lung
carcinoma cells
E1B-55K Inhibition Inactivates p53 293 cells
E3-6.7 Inhibition Blocks TRAIL-induced apoptosis Cytotoxic T cells
E3 RID Inhibition Inhibits E1A or TNF-induced apoptosis HT29.14S cells
Decreased presentation of Fas on the cell
surface
Jurkat, CEM, and HuT78
cell lines
E3-14.7K Inhibition Inhibits TNF and TRAIL-induced apoptosis Fibroblast C3HA cell lines
Inhibition inhibits MHC class I transport to the cell
surface
T lymphoma cell line
E4 orf 6 Inhibition Blocks p53 H1299 cells
Human cytomegalovirus
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Inhibition Inhibits TNF-induced apoptosis HeLa cells
Parasites Apoptosis Proposed or demonstrated mechanism Cell type
Toxoplasma gondii Inhibition Increased antiapoptotic Bcl-2 family Fibroblasts




Induction IFN-γ T cell
Plasmodium falciparum Increased Ca level Erythrocytes
Caspase 8 and caspase 9 activation Endothelial cells
Trypanosoma brucei Induction Intrinsic pathway Neuronal cell
Trypanosoma cruzi Inhibition PI3-K/PKB pathway Schwann cells
Leishmania donovani Induction Intrinsic pathway Neutrophils
Table 1. Microorganisms that induce and/or inhibit host cell apoptosis
Apoptosis is induced by both intrinsic and extrinsic pathways. Due to their key role in cell
survival, mitochondria represent attractive targets for pathogens. Several pathogens, includ‐
ing both viruses and bacteria, have been shown to target mitochondria in order to interfere
with the host cell apoptotic machinery. For example, bacterial pore-forming toxins such as the
neisserial porin PorB, which causes rapid Ca+2 influx into target cells and induces apoptosis,
exhibit striking structural and functional homology with the mitochondrial anion channels
that mediate mitochondrial permeability transition and apoptosis [31]. Apoptosis, which is
executed by caspase activity, can be induced either by the ligation of death receptors or by the
release of another proapoptotic factor cytochrome c from mitochondria. Apoptotic stimuli
(either death ligands, binding to death receptors, or any of the multitude of agents that induce
apoptosis) are received by some cellular receptor. In the case of death receptors, this directly
causes caspase activity [32].
New studies have shown that many bacterial pathogens can prevent apoptosis during
infection. Bacteria inhibits apoptosis by the use of multiple mechanisms: the protection of the
mitochondria and prevention of cytochrome c release (i.e., Chylamidia sp. and/or Neisseria sp.),
the activation of cell survival pathways (i.e., Salmonella sp. and/or Rickettsia sp.), the inhibition
of caspases, and the activation of phosphoinositide 3-kinase (PI3K)-Akt/protein kinase B (PKB)
pathway and interaction with cellular caspases (i.e., Shigella sp. and/or Legionella sp.) [33]. The
PI3K/Akt pathway is also a strong activator of cyclin D1, a critical player in cell cycle progres‐
sion. Cyclin D1 protein levels are also regulated by glycogen synthase kinase 3 (GSK-3). GSK-3




tion induced by GSK-3 is inhibited by the activation of PI3K/Akt pathway because Akt directly
phosphorylates and inactivates GSK-3 [34]. c-Fos is a transcriptional regulator that can elevate
the expression of many proliferatory genes. PI3K/Akt pathway executes some of its antiapop‐
totic effects through transcription factors such as Elk-1 and c-Fos. The activation of the
Raf/MEK/ERK pathway is associated with the increased expression of antiapoptotic proteins.
The Raf/MEK/ERK cascade can also activate the PI3K/Akt pathway. Raf has been shown to
directly phosphorylate Bad and Bcl-2 to exert antiapoptotic effects. Depending on cell type as
well as apoptotic stimulus, Raf can inhibit or promote apoptosis [35]. Toll-like receptors (TLR)
have been described to have both apoptosis-inducing and inhibiting capacity. Early reports
have linked the activation of TLR2 to the induction of apoptosis through the adapter MyD88
[36]. At the same time, TLR-signaling has clearly an antiapoptotic activity via NF-κB and the
PI3Kpathways. NF-κB induces antiapoptotic gene expression [37].
6.1. Pseudomonas
Pseudomonas aeruginosa can cause disease in animals, including humans. The symptoms of such
infections are generalized inflammation and sepsis. If such colonizations occur in critical body
organs such as the lungs, the urinary tract and kidneys, the results can be fatal [38]. P.
aeruginosa kills mammalian cells by an activation of the endogenous CD95 (Fas)/CD95 ligand
(Fas-ligand) system. An upregulation of cell surface CD95 and CD95 ligand resulting in the
activation of this death receptor has been recently shown to be pivotal for the induction of
apoptosis by several P. aeruginosa strains. The upregulation of CD95 and the CD95 ligand on
cells infected with P. aeruginosa depends on the function of the type III secretion system (T3SS).
The ligation of the receptor stimulates caspases, mitochondrial changes, and finally execution
of apoptosis in vitro and in vivo [30]. The binding of CD95 by the CD95 ligand upon upregu‐
lation induces the activation of caspases and JNK. In addition, reactive oxygen intermediates
in the induction of P. aeruginosa triggered death [39].
6.2. Neisseria
Neisseria gonorrhoeae is the etiological agent of the sexually transmitted disease gonorrhea. It
penetrates the mucosa, enters phagocytes and epithelial cells, and causes a massive inflam‐
matory response in the subepithelial tissue [40]. Several factors play a role in infection, for
example, the pili, which mediates primary adherence; the Opa proteins, which mediate
adhesion and invasion; and the PorB porin [41,42]. There is conflicting information regarding
the effects of neisserial porins on apoptosis. These discrepancies may be due to the specific
responses of different cell types, culture conditions, and bacterial strains. N. gonorrhoeae porin
PorB1B interacts with HeLa cell mitochondria and induces calcium eflux and apoptosis [43].
Massari et al. [44] showed that Neisserial PorB is translocated to the mitochondria of HeLa cells
infected with Neisseria meningitidis and prevent apoptosis by the inhibition of cytochrome c
release. Massari et al. [44] speculated that differences in cell types or porin purification explain
the discrepancies between the results. N. gonorrhoeae also increases the transcription of host
antiapoptotic genes. These genes include bfl-1, cox-2 and c-IAP-2, each coding for a product
that acts to inhibit apoptosis.
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Bfl-1 is a member of the Bcl-2 family of apoptotic regulators and has been characterized to have
a protective effect on host cells when overexpressed. Anti-apoptotic Bcl-2/Bcl-XL interact with
the mitochondrial porin VDAC, thus blocking the opening of the PT and/or mitochondrial
membrane depolarization and inhibiting cytochrome c release [45]. N. gonorrhoeae can inhibit
apoptosis induced by the intrinsic and extrinsic apoptosis inducers staurosporine (STS) and
TRAIL in HL-60 cells and primary polymorphonuclear leukocytes (PMLs) [46]. In addition
Follows et al. [47] showed that N. gonorrhoeae infection in human endocervical epithelial cells
induced NF-κB activation and resulted in the increased gene expression of the NF-κB-
regulated antiapoptotic genes Bfl-1 and/or cIAP-2.
6.3. Shigellas
The genus Shigella consists of four pathogenic “species”: S. dysenteriae, S. flexneri, S. sonnei, and
S. boydii. S. flexneri causes dysentery (shigellosis) by invading the human colonic mucosa. It
directly activates proapoptotic signaling pathways to initiate apoptosis in macrophages. It
crosses epithelium and goes to lamina propria of intestinal villi. The three proposed effectors
of S. flexneri internalization are invasion plasmid antigens (Ipa) IpaB, IpaC, and IpaD, all of
which are encoded on the pathogen’s 230-kb virulence plasmid. These effectors cause caspase
1 activation. Activated caspase 1 then cleaves and activates prointerleukin (proIL)-1β and
proIL-18, which are proinflammatory cytokines involved in host inflammatory [48,49]. The
secretion of Ipa proteins is dependent on T3SS, which is encoded by 20 genes in the mxi-spa
locus of the virulence plasmid. Additional T3SS effector proteins are secreted through the T3
needle when the bacteria are inside the cytoplasm of the host cell [50]. S. flexneri kills more of
macrophages and promotes the spreading of the bacteria because of the release of interleukin
1β (IL-1β). IL-1β recruits PMLs to the infection sites. The PMLs cross the intestinal epithelium
altering the integrity of this epithelial barrier. This promotes massive secondary invasion of
the bacteria and acute inflammation [51]. S. flexneri infects enterocytes from the basolateral
side. The ultrastructural morphology of infected macrophages includes condensation of
chromatin at the nuclear boundary blebbing at the cell surface, dilation of the endoplasmic
reticulum, and cytoplasmic vacuolization. This is identical to the morphology of cells under‐
going apoptosis [52]. Shigella does not induce apoptosis in epithelial cells because these
intestinal cells are the primary sites for intracellular bacterial proliferation during shigellosis.
It was shown that in the presence of STS, S. flexneri inhibits apoptosis by preventing the
activation of caspase 3. This happens because of both cytochrome c release from the mito‐
chondria and caspase 9 activation [53]. Faherty et al. [54] suggested that Shigella is protected
from apoptosis in epithelial cells by various mechanisms. The bacteria prevent cytochrome c
release from the mitochondria through the upregulation of Bcl-2 proteins. Second, the extrinsic
pathway of apoptosis is inhibited from in vivo stimuli such as TNF and FasL. Third, infection
leads to the induced expression of JNK and NF-κB, which has many prosurvival effects,
including the increased expression of the IAPs (BIRC4, BIRC1, BIRC5, and BIRC7), the Bcl-2
family, and the caspase 8 inhibitors. Finally, the bacteria prevent caspase 3 activation to provide
downstream protection in the presence of strong apoptosis inducers. Through the use of T3SS
effector proteins, the bacteria could directly generate mitochondrial protection, extrinsic




Shiga toxins comprise a family of structurally and functionally related protein toxins expressed
by S. dysenteriae serotype 1 and multiple serotypes of Escherichia coli. Shiga toxins cause bloody
diarrheal diseases, which may progress to life-threatening extraintestinal complications. The
kidneys and central nervous system are the organs most frequently involved [55]. Shiga toxins
induce apoptosis in human epithelial, endothelial, myeloid, and lymphoid cells in vitro and
appear to induce apoptosis in rabbit neurons in vivo. Apoptosis induction involves the
activation of both extrinsic (caspases 8, 6, and 3 activation) and intrinsic (Bid generation,
cytochrome c release, and/or caspase 9 activation) pathways. Alterations in the balanced
expression of pro- and antiapoptotic Bcl-2 family members also contribute to apoptosis
induction [56].
6.4. Salmonellas
Salmonella cause an acute localized inflammation in the intestine. Salmonella enterica serovar
Typhimurium, one of the most common food-borne pathogens, causes self-limiting gastroen‐
teritis in humans and a similar diarrheal disease in calves and pigs. Salmonella typhimurium can
access systemic tissue (mainly spleen and liver) via the lymphatic system and the Peyer’s
patches. Salmonella uses specific virulence factors to invade other cell types such as T3SS. S.
typhimurium directly activate apoptosis in macrophages [57]. Salmonella invasion protein (Sip)B
activates ICE (IL-1β converting enzyme). Caspase 1 activation in Salmonella-infected macro‐
phages results in the production of active IL-1β and IL-18 and rapid cell lysis with the release
of proinflammatory intracellular contents [58]. Knodler et al. [59] showed that S. enterica
serovar typhimurium effector protein SopB protects epithelial cells from apoptosis by sustained
the activation of Akt. SopB has antiapoptotic activity in infected epithelial cells, which is
dependent on the phosphatase activity of SopB and the presence of Akt. PI3K-Akt/PKB-
pathway protect against apoptosis by the phosphorylation of the proapoptotic Bad. This
pathway prevents cytochrome c release.
6.5. Listeria monocytogenes
Listeria monocytogenes, a facultative anaerobe and/or intracellular bacterium, is the causative
agent of listeriosis. L. monocytogenes, similar to Shigella, lyses the phagosomal membrane and
escapes into the cytosol to initiate an intracellular infection, a process that is mediated by a
secreted pore-forming toxin, listeriolysin O (LlyO). L. monocytogenes induces LlyO-dependent
apoptosis in a variety of cell types, including hepatocytes, lymphocytes, and dendritic cells.
LlyO might insert into the mitochondrial membrane causing the release of cytochrome c. In
addition, the insertion of LlyO into the mitochondrial and/or endoplasmic reticulum mem‐
brane may stimulate calcium efflux, thereby activating the calpain and/or caspases [60,61].
Stavru and Cossart [62] showed that LlyO is responsible for mitochondrial network disruption
along with a decrease in mitochondrial membrane potential and intracellular ATP levels.
However, L. monocytogenes does not induce apoptosis in macrophages but causes LlyO-
mediated necrosis [63].
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6.6. Chlamydiae
Two species of chlamydiae commonly infect humans, Chlamydia trachomatis and Chlamydia
pneumoniae. C. trachomatis causes trachoma, a scarring eye infection in developing countries.
C. pneumoniae causes pneumonia [64]. Chlamydia species require differentiation to produce
sufficient infectious elementary bodies to spread to adjacent cells. In an infection, elementary
bodies are taken up by a host cell and begin their cycle inside a membrane-bound vacuole in
the host cell cytosol. During the early stages of infection, Chlamydia has antiapoptotic effect
that helps to maintain the metabolic activities of the infected cell. It was shown that C.
trachomatis has antiapoptotic effect in epithelial cells and macrophages by blocking the release
of cytochrome c [65]. C. pneumoniae also inhibited apoptosis through an additional activity that
was described as blocking caspase activation by cytochrome c in a cell-free system [66]. The
activation of the host cell apoptotic pathways in the late stages of infection may facilitate
dispersal of the bacteria and initiate a host inflammatory response. The various subfamilies of
the Bcl-2-family of proteins play a decisive role in this event. The trigger of cytochrome c-
release is the activation of one or several BH3-only proteins. Bcl-2 and its antiapoptotic
homologues can bind active BH3-only proteins and probably by this interaction block
apoptosis [67]. Du et al. [68] demonstrated another way of that inhibiting apoptosis involves
the activation of Raf/MEK/ERK survival pathway.
6.7. Yersinia
Yersinia invades epithelial cells, fibroblasts, and M cells in mammalian cells in vitro and in
vivo [69,70]. Yersinia enterocolitica and Yersinia pseudotuberculosis are transmitted by fecal-oral
route and cause gastrointestinal syndromes lymphadenitis and septicemia. Yersinia pestis is
typically transmitted through the bite of an infected flea and causes bubonic and/or septicemic
plague. Yersinia virulence plasmid encodes T3SS and 6 known effector proteins termed
Yersinia outer proteins (Yops) [71]. The translocation of the effector molecule YopJ (Y.
pseudotuberculosis), YopP (Y. enterocolitica), or YopJKIM (Y. pestis) into the cells has been shown
to rapidly activate apoptosis in macrophages and dendritic cells but not in human epithelial
cells [72,73]. Yersinia YopJ/P represses the activation of ERK and the NFКB. More recent studies
indicate that YopJ has acetyltransferase activity, acetylating Ser and Thr residues critical for
the activation of IKK-B and ERK kinases in Yersinia-infected macrophages [74,75]. Also, the
TLR4 has been shown to act as a potent inducer of apoptosis in macrophage [76]. YopJKIM has
two amino acid changes that give it an enhanced ability to inhibit survival signals in macro‐
phages. The increased apoptosis may cause membrane permeability resulting in the efflux of
K+ and activation of caspase 1. It was suggested that caspase 1 activation is a normal outcome
of a type of apoptosis that is triggered in naive macrophages by TLR4 signaling combination
with pathogen interference with ERK and NF-κB pathways [77]. YopJ and/or YopP did not
induce pronounced apoptosis in human PMLs. It was suggested that Yersinia inhibition of
PMLS ROS production plays a role in evasion of the human innate immune response in part





Legionella pneumophila invades and replicates within alveolar macrophages, monocytes, and
possibly alveolar epithelial cells and causes Legionnaires disease. The expression and/or
export of apoptosis-inducing factor(s) in L. pneumophila is regulated by the Dot/Icm type IV-
like secretion system [79,80].
L. pneumophila utilizes several strategies to ensure intracellular replication and protect itself
against the host immune system. These are the following: (1) upon entry into a human
phagocyte, L. pneumophila becomes contained in a vacuole called Legionella-containing
phagosome that avoids the typical fusion with the lysosome. L. pneumophila promotes the
cleavage of Rabaptin-5 by caspase 3, thus preventing the default phagosome-lysosome fusion.
(2) L. pneumophila promotes the cleavage of Rabaptin-5 by caspase 3, thus preventing the
default phagosome-lysosome fusion. (3) L. pneumophila does not activate caspases 1 and 7 in
human monocytes consequently aborting the phagosome-lysosome fusion. (4) L. pneumophi‐
la inhibits host cell apoptosis by upregulating antiapoptotic genes. (5) L. pneumophila controls
the local balance of activating cytokines (IFN-γ and/or TNF-α) that inhibit its replication and
inhibiting cytokines (IL-10) that allow its survival. (6) L. pneumophila activates the NF-κB
pathway to maintain host cell survival and/or 7-L. pneumophila modulates other innate immune
responses to establish a replicative niche [81].
6.9. Escherichia coli
E. coli K1 is a leading causative agent of neonatal meningitis. OmpA of E. coli can directly
interact with monocytes and macrophages for entry. Some E. coli serotypes produce a Shiga-
like toxin that can bind to human intestinal epithelium and produce Shiga-like toxins, which
are associated with hemorrhagic colitis and the hemolytic-uremic syndrome [82]. One pathway
involving apoptosis is mediated by death receptors such as CD95 and TNF-R. Intrinsic
apoptotic pathway is involved in the Shiga-like toxin-mediated apoptosis of epithelial cells
[83]. E. coli K1 induces the expression of the antiapoptotic protein BclXL for its own survival
and that of host macrophages. In addition, the bacteria may also block the activation of
caspases. Besides upregulating BclXL, OmpA+ E. coli interaction with macrophages may alter
the signaling pathways of the host cell to use it as a protected reservoir for the time required
to reach septic levels [84,85].
6.10. Rickettsia
Rickettsia is a genus of nonmotile, Gram-negative, non-spore-forming, and/or highly pleomor‐
phic bacteria. Rickettsia rickettsii is a unicellular Gram-negative coccobacillus. R. rickettsii is most
commonly known as the causative agent of Rocky Mountain spotted fever [86]. R. rickettsii
prevents apoptosis by the activation of cell survival pathways. R. rickettsii induces NF-κB
activity and the upregulation of prosurvival proteins, the downregulation of proapoptotic
proteins, and a lack of cytochrome c release in endothelial cells. Bechelli et al. [87] performed
a screening of pro- and antiapoptotic genes that were differentially expressed in human
microvascular endothelial cells during R. rickettsii infection and after staurosporine challenge.
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A total of 14 genes were significantly upregulated of which 8 (TRAF1, BNIP2, BCL2L1, TRAF3,
BIRC2, BNIP3L, AKT1, and BIRC5) are known apoptosis suppressors while 6 are known to
promote apoptosis (BOK, BCL2L13, DAPK2, TP53, ABL1, and BAK1). However, R. rickettsii
efficiently infects neuronal cells and that the infection causes apoptotic death of neuron [88].
6.11. Mycobacterium
Mycobacterium tuberculosis is the causative agent of most cases of tuberculosis. M. tuberculo‐
sis infected macrophages die by (a) necrosis, a death modality defined by cell lysis, or (b)
apoptosis,  a  form  of  death  that  maintains  an  intact  plasma  membrane.  Necrosis  is  a
mechanism used by bacteria to exit the macrophage, evade host defenses, and spread. M.
tuberculosis  is  complex  and  includes  both  the  induction  of  cell-death  and  cell-survival
signals. It induces apoptosis in macrophages in vitro and in vivo [89]. Apoptosis occurs by
TNF  pathway.  In  addition,  MOMP  leading  to  the  activation  of  the  intrinsic  apoptotic
pathway is  required.  Both  pathways  lead  to  caspase  3  activation  which  then  results  in
apoptosis [90]. Bacteria cell wall components connect TLR-2 molecules. M. tuberculosis also
protects cells against apoptosis via two key pathways: first, through the induction of TLR-2-
dependent activation of the NF-κB cell  survival pathway, and second, by enhancing the
production of soluble TNFR-2 (sTNFR2), which neutralizes the proapoptotic activity of TNF-
α. M. tuberculosis  can prevent apoptosis in alveolar epithelial cells. Danelishvili et al.  [91]
showed that M. tuberculosis infection of macrophages results in the downregulation of the
Bcl-2  gene  and  the  upregulation  of  Bax  and  Bad  proapoptotic  genes.  In  contrast,  the
increased expression of Bcl-2 and the inhibition of Bax and Bad genes were observed in
alveolar epithelial cells. M. tuberculosis infection was associated with the repression of the
Bcl-2 gene and the induction of p53 in human macrophages. In alveolar epithelial cells, the
expression of p53 was unchanged during M. tuberculosis infection [92].
7. Viral infections
After infecting target cells, viruses replicate to produce large number of progeny virions and
spread the progeny to initiate the next round of infection. Some viruses encode specific proteins
to optimize their replication. Infection by viruses, however, triggers the apoptosis of the
infected cell to restrict virus infection. This is done by reprogramming of the host cell apoptotic
pathway to effect death of the infected host cell before the release of progeny viruses. In order
to ablate host defense mechanisms, viruses have evolved proteins that are able to inhibit or
delay the host protective actions by targeting strategic points in the apoptotic pathways [93].
Apoptosis can be induced by intrinsic or extrinsic signals (Table 1). Intrinsic signals may result
from viral infection and include stress, cell cycle arrest, cytoplasmic calcium perturbation, and
DNA damage. Extrinsic signals arise as a result of the host immune response through TNF-
receptor or Fas activation or via delivery of proteases by cytotoxic lymphocytes. Once induced,
apoptosis may eliminate infected cells prior to release of viral progeny [94, 95]. Many viruses
have been shown to induce apoptosis, either as a mechanism for the release and dissemination




of infected cells and therefore preventing the spread of the virus [96]. Innate and the acquired
immune system induce apoptosis as a host defense against viral infections. The innate immune
system directly activates inflammatory cells such as macrophages (e.g., granulocytes, Kupffer
cells in the liver) and natural killer (NK) cells, which may directly cause death of the infected
cells. On the other hand, viral RNA or proteins can bind to intracellular molecules that
modulate or directly induce cell death [97]. In this immune cell-independent, virus-induced
apoptosis of the host cell protein kinase R (PKR) and the cytoplasmic RNA helicase RIG-I play
important roles [98]. PKR acts via the downstream transcription factor eIF-2α [99]. At the same
time, acquired immune system works to eliminate the virus and the recognition of viral
antigens presented by specific cells (e.g., dendritic cells). The antigen-primed CD8+-T-lym‐
phocytes cytotoxic T lymphocytes directly kill infected cells via direct cell-cell contact and
release of cytotoxic and/or antiviral cytokines (e.g., interferons IFNs and/or TNF-α), whereas
IFN-γ and IFN-α are also able to eliminate the virus without killing the host cell [100].
The IFNs are considered to play a critical role in innate immunity to viral infection and aside
from effectively preventing intracellular viral replication can also mediate the activation and
recruitment of the adaptive immune response. The IFNs can be induced by a number of stimuli,
including viruses and dsRNA through mechanisms involving the activation of interferon
regulatory factor (IRF-3), NF-κB, and perhaps the dsRNA-dependent PKR and the JNK2
pathway, all of which have been reported to be mediators of cell death [101,102].
7.1. Hepatitis C virus
Hepatitis C virus (HCV) causes liver cirrhosis and hepatocellular carcinoma [103]. In hepato‐
cytes, apoptosis induction via cytotoxic T lymphocytes and macrophages largely occurs via
extrinsic pathway. Ligand binding activates caspase 8 signaling cascade [104]. Another
mechanism of apoptosis involves viral protein and their interactions. HCV core protein has
been shown to be proapoptotic and antiapoptotic effects [105]. Machida et al. [106] showed
that the expression of HCV proteins may directly or indirectly inhibit Fas-mediated apoptosis
and death in mice by repressing the release of cytochrome c from mitochondria.
7.2. HIV
Human immunodeficiency virus type 1 (HIV-1)-infected individuals often suffer from
neurological complications such as memory loss, mental slowing, and gait disturbance [107].
HIV infection is associated with a progressive decrease in and/or loss of CD4+ and the decline
of CD8+ T cells and viral replication [108]. Inappropriate signaling through the binding of the
HIV-1 envelope to the CD4 may induce abnormal programmed CD4+ T-cell death. Viral
proteins such as HIV-1 gp120 have an important role development in HIV-associated apop‐
tosis. HIV proteins implicated in the induction of apoptosis in vitro include tat, nef, vpr, and
protease. Cross-linking of bound gp120 on human CD4+ T cells followed by signaling through
the T-cell receptor for antigen was found to increase susceptibility to Fas and result in apoptosis
[109,110]. In addition, deregulation in cytokine production occurs during HIV infection,
perturbing the immune response. The overproduction of IL-4 and/or IL-10 cytokines is known
to increase susceptibility to activation-induced cell death. IFN-α produced by HIV-1-infected
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dendritic cells contributes to CD4 T-cell apoptosis by the TRAIL/DR5 pathway [111]. HIV-1
protein Env triggers apoptosis by the transactivation of the p53-dependent genes Puma and
Bax [112]. HIV Nef is able to induce apoptosis by extrinsic pathway [113,114].
7.3. Rabies virus
Rabies virus (RV) is a neurotropic virus and travels to the brain by following the peripheral
nerves. RV, a member of the genus Lyssavirus of the family Rhabdoviridae, is known to cause
fatal encephalomyelitis in many mammalian species. RV has developed two main mechanisms
to escape the host defenses: (1) its ability to kill protective migrating T cells and (2) its ability
to sneak into the nervous system without triggering the apoptosis of the infected neurons and
preserving the integrity of neurites [115]. In one of the studies, Ubol et al. [116] showed the
expression of Bax and caspase 1 activation in RV-infected neuroblastoma cells. In another
study, the expression of caspase gene Nedd-2 was significantly upregulated in infected adult
and suckling mice [117]. Thoulouze et al. [118] showed that apoptosis induced by rabies virus
involves the activation of caspase 8 and disappearance of procaspases 9 and 3. In addition, AIF
translocated from the cytoplasm to the nucleus, suggesting that caspase-independent pathway
is also involved in RV-induced apoptosis. Sarmento et al. [119] showed that AIF, a caspase-
independent apoptotic protein, was upregulated and translocated from the cytoplasm to the
nucleus postinfection, suggesting that apoptosis induced by RV induces apoptosis by both the
caspase-dependent and caspase-independent pathways.
7.4. Epstein-Barr virus
Infection with Epstein-Barr virus (EBV) is very common and usually occurs in childhood or
early adulthood. In fact, up to 95% of people in the U.S. have been infected with EBV. EBV is
the cause of infectious mononucleosis (also termed “mono”), an illness associated with fever,
sore throat, swollen lymph nodes in the neck, and sometimes enlarged spleen. Less commonly,
EBV can cause more serious disease. To establish a persistent latent infection, EBV must access
the memory B-cell compartment and reside within long-lived peripheral B cells where few
viral gene products are expressed in order to escape immune detection [120]. EBV encodes two
viral Bcl-2 proteins, BHRF1 and BALF1, with apparently redundant functions. The viral BHRF1
gene expresses a Bcl-2 homologue protein that resembles Bcl-2 in its subcellular localization
and capacity to enhance B-cell survival [121]. In vitro, EBV infects resting human B lymphocytes
and transforms them into lymphoblastoid cell lines (LCLs). In LCLs, 11 so-called latent genes
are consistently expressed. These are the EBV nuclear antigens EBNA1, EBNA2, EBNA-LP,
EBNA3A, B, and/or C and the latent membrane proteins LMP1, LMP2A, and B and two
noncoding RNAs [122]. LMP1 indirectly inhibits apoptosis by upregulating several cellular
antiapoptotic genes presumably through the induction of the NF-κB pathway [123].
7.5. Baculovirus
Baculovirus antiapoptotic genes include p35, which encodes the most broadly acting caspase
inhibitor protein known and IAP genes [124]. The baculovirus IAP blocks apoptosis induced




number of highly conserved Cys⁄His motifs known as baculoviral IAP repeats (BIRs). The BIR
domains bind directly to caspases and inhibit their proteolytic activity and molecules that
contain an IAP-binding motif (second mitochondrial-derived activator of caspases and Omi)
antagonize IAP function via binding to BIR motifs displacing IAP binding to caspases or by
promoting their degradation. Therefore, vIAPs act downstream of mitochondria, inhibiting
the activity of procaspase 9 and effector caspases 3 and 7 [125]. The antiapoptotic protein p35
from baculovirus is thought to prevent the suicidal response of infected insect cells by
inhibiting caspases [126]. Zhou et al. [127] showed that purified recombinant p35 inhibits
human caspases 1, 3, 6, 7, 8, and 10. There may be interaction of the baculovirus antiapoptotic
protein p35 with caspases. Sah et al. [128] demonstrated the ability of the p35 gene to inhibit
oxidative stress-induced apoptosis. Oxidative damage to cellular macromolecules such as
nuclear and mitochondrial DNA and proteins caused by reactive oxygen species is considered
to be of key importance in the aging process. The chain of oxidative reactions initiated by ROS
eventually knocks down the crucial biomolecules, thereby driving the cellular machinery to
undergo apoptosis via the activation of caspases, which ultimately brings about the execution
of cell death. p35 is able to directly mop out free radicals and prevent cell death by also acting
in an oxidant-dependent pathway at a very upstream step in the cascade of events associated
with oxidative stress-induced apoptosis [129].
7.6. Human papillomavirus (HPV)
HPVs are small DNA viruses that are known to be the most common etiological agents in
cervical cancer. HPVs are implicated in the mucosal and epithelial infections that may range
from a benign lesion to a malignant carcinoma [130]. Recent studies have shown that 13
different types of HPV are associated with carcinogenesis. HPVs are DNA tumor viruses
whose genome is organized in three regions: the early gene (E1 to E7), the late gene (L1 and
L2) regions, and the upper regulatory region (URR). The late region units, L1 and L2, encode
for viral capsid proteins during the late stages of virion assembly. E1 and E2 encode proteins
that are vital for extrachromosomal DNA replication and the completion of the viral life cycle.
The E4 protein plays an important role for the maturation and replication of the virus. The E5
in open reading frame (ORF) interacts with various transmembrane proteins like the receptors
of the epidermal growth factor, platelet-derived growth factor β, and colony stimulating
factor-1. E6 and E7 ORF encode for oncoproteins that allow replication of the virus and the
immortalization and transformation of the cell that hosts the HPV DNA [131]. The HPV E2
regulates the transcription of E6/E7 and facilitates apoptosis via p53-dependent pathway in
HeLa cells [132]. HPV E7 is involved with cell cycling and binds to the retinoblastoma tumor
suppressor protein and related proteins and induces apoptosis in mouse lens [133]. The
inactivation of p53 by E6 should lead to a reduction in cellular apoptosis. Numerous studies
showed that E6 could in fact sensitize cells to apoptosis. HPV E6 induce the degradation of
p53. E6 expression correlated with the prolonged expression of Bcl-2 reduces the elevation of
Bax and loss of p53. Several studies have shown that E2 could also induce apoptosis inde‐
pendent of its effects on transcription of E6 and E7 [134-136]. Tan et al. [137] showed that HPV16
E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human
cervical carcinoma cells. Moreover, HPV-16 E6 was shown to bind TNF R1 and protect cells
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from TNF-induced apoptosis in mouse fibroblasts and human histiocyte/monocyte and
osteosarcoma cells. Caspase 3 and caspase 8 activation were significantly reduced in E6-
expressing cells [138].
7.7. Adenovirus
Adenoviruses (Ads) were first described as the etiological agents isolated from human
adenoids and respiratory secretions that cause spontaneous cytopathic effects in cultures of
human cells. Adenovirus has evolved ways to commandeer host cell machinery for successful
entry, viral DNA replication, and propagation of progeny virions. Adenoviral proteins interact
with host-cell proteins to either exploit or inhibit cellular functions for the purpose of viral
propagation. The Ad genome is a 36 kbp linear double-stranded DNA molecule that encodes
five early transcription units (E1A, E1B, E2, E3, and E4), two delayed early units, and one major
late unit that is processed to make five families of late mRNAs. The early genes are transcribed
before viral DNA replication begins, and the late proteins are made following the onset of
replication [139]. At least 51 serotypes have been distinguished based on resistance to neu‐
tralization by antibodies specific to other known serotypes. These are divided into six sub‐
groups (A-F) based on hemagglutination patterns, oncogenicity, and genome homologies. The
common subgroup C Ads, which include Ad serotypes 1, 2, 5, and 6, are endemic virtually all
over the world. They cause mild upper respiratory tract infections in young children [140].
Early in infection, the expression of E1A drives the host cell into the S phase of the cell cycle
in order to induce DNA synthesis that is required for viral replication. The genes in the E3
region of Ad encode several proteins that function to protect the virus-infected cell from host
immune responses [141]. Table 1 describes the adenovirus immunoregulatory proteins and
how they function to block or induce apoptosis of infected cells [142-150].
7.8. Human cytomegalovirus
Human cytomegalovirus (CMV), a beta herpes virus with a widespread distribution, is a major
cause of morbidity and mortality in immunocompromised individuals such as organ trans‐
plant recipients and patients with AIDS. During pregnancy, CMV is a major cause of congenital
disease [151]. CMV genes UL36 and UL37 encode viral inhibitor of caspase-8-induced
apoptosis (vICA) and viral mitochondria inhibitor of apoptosis (vMIA), respectively. Skalet‐
skaya et al. [152] identified a human cytomegalovirus cell-death suppressor denoted vICA and
encoded by the viral UL36 gene. vICA inhibits Fas-mediated apoptosis by binding to the
prodomain of caspase 8 and preventing its activation. vMIA blocks cytochrome c release and
activation of downstream effector caspases in a manner analogous to Bcl-2 homologues. Like
Bcl-2, vMIA localizes to mitochondria and inhibits mitochondrial permeabilization induced
by apoptotic signals [153]. vMIA also counteracts serine protease HtrA2⁄Omi (high tempera‐
ture requirement protein A2⁄Omi stress-regulated endonuclease)-dependent cell death and
allows infected cells to survive and continuously produce a virus for several days [154].
Additional human CMV gene products, including IE1 and IE2, as well as the murine CMV
UL45 homologue may influence cell susceptibility to apoptosis [155]. Transient transfection




each inhibit the induction of apoptosis by TNF or by the E1B 19-kDa-protein-deficient
adenovirus. IE1 and IE2 proteins inhibit apoptosis in part by modulating the activity of
p53[156]. In addition, IE1 and IE2 and the viral RNA beta 2.7, which bind to the mitochondrial
respiratory complex I, maintain ATP production late in infection and prevent death induced
by mitochondrial poison [157].
8. Apoptosis and parasitic infections
Apoptosis plays crucial roles in the interaction between the host and the parasite. This includes
innate and adaptive defense mechanisms to restrict intracellular parasite replication as well
as regulatory functions to modulate the host’s immune response. During their evolution,
parasites have developed mechanisms to induce or avoid host cell apoptosis in order to be able
to survive and complete their life cycle (Table 1). Among the factors involved in that balance
in infected organisms, the time of apoptosis (early or late occurrence), the cell type, and the
type of parasitism (intracellular or not) are the major modulators. For example, the early
apoptosis of host cells could contribute toward their fight against infection by intracellular
parasites; equally, early apoptosis could favor the penetration of the parasite. The late
apoptosis of cells of the defense system could be beneficial to the host clearing excess cells,
thereby avoiding the detrimental effects of excessive inflammatory response in the tissue that
they would cause [158].
8.1. Toxoplasma gondii
Toxoplasma gondii is a species of parasitic protozoa in the genus Toxoplasma. Humans can
become infected with T. gondii, either through contact with soil contaminated by cat feces or
by eating infected meat. Toxoplasmosis is usually asymptomatic because our immune system
keeps the parasite from causing illness. The disease is more problematic for pregnant women
and people who have weakened immune systems. Some results indicate a strong correlation
between schizophrenia, brain cancer, and toxoplasmosis [159]. Toxoplasma promote or inhibit
apoptosis. Begum-Haque et al. [160] demonstrated marked difference in the death of activated
T cells between early (day 3 post infection) and acute (day 6 post infection) stage of T. gondii.
The decreased production of IL-2 and augmented synthesis of IL-10 during acute stage of T.
gondii infection may have a role in the enhanced level of apoptosis. It has been suggested that
the apoptosis of T lymphocytes in T. gondii infection is associated with the virulence and
density of the parasite in the host. In T. gondii infection, IFN-γ locally produced in Peyer’s
patches contributes to the induction of apoptosis in Peyer’s patch T cells [160]. T. gondii inhibits
the apoptosis of host cells by indirect and direct mechanisms. Granulocyte colony-stimulating
factor and granulocyte-macrophage cerebrospinal fluid secreted by T. gondii-infected human
fibroblasts increased the expression of antiapoptotic Bcl-2 family member Mcl-1 and abolished
apoptosis in neutrophils in vitro indirectly [161]. Many studies have shown that T. gondii has
evolved strategies to directly inhibit cell apoptosis by various mechanisms: (a) increased
expression of antiapoptotic members of the Bcl-2 protein family; (b) inhibition of the cyto‐
chrome c release; (c) upregulation of IAPs; (d) activation of NF-κB by T. gondii in distinct cell
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types or under distinct conditions thereby inducing the transcription of genes encoding
antiapoptotic molecules, including Bfl-1 and IAPs; and/or (e) degradation of the PARP as
described is involved in the inhibition of apoptosis. Although direct evidence is still lacking,
it appears plausible that diminished PARP levels in Toxoplasma-infected cells may inhibit
apoptosis in a caspase-independent fashion [162].
8.2. Plasmodium falciparum
Plasmodium falciparum is the agent of malaria. Enhanced levels of RBC apoptosis have been
observed in clinical disorders in which anemia is a common feature such as iron and renal
insufficiency, thalassemia, sickle-cell disease, and apoptosis has been associated to cerebral
malaria, thrombocytopenia, and lymphocytopenia in malaria infection [163].
P. falciparum induces oxidative stress, which in turn activates the Ca+2 permeable cation
channels followed by Ca+2 entry, and the stimulation of eryptosis has been coined to describe
the suicidal erythrocyte death. The Ca+2 uptake, however, eventually triggers eryptosis of the
parasitized erythrocyte, and thus the parasitized erythrocytes is doomed to be phagocytosed
by macrophages [164].
P. falciparum firstly enter red blood cells. Second, parasitized red blood cell sticks endothelial
cells, inducing the expression of iNOS in brain cells. The activation of caspases 8 and 9 results
in apoptosis and blood-brain barrier disruption [165].
8.3. Trypanosomatids
Trypanosomatids are the causative agents of diseases such as the Chagas disease and the
African sleeping sickness [166]. Trypanosomatids lack some of the key molecules contributing
to apoptosis in metazoans like caspase genes, Bcl-2 family genes, and the TNF-related family
of receptors. Apoptosis triggered in response to heat shock, prostaglandins, antibodies, and
mutations in cell cycle regulates genes [167]. These stimuli result in loss of ΔΨm, generation
of ROS, lipid peroxidation, and increase in cytosolic Ca2+. This also potentiates the release of
cytochrome c and EndoG into the cytoplasm and the activation of proteases and nucleases to
dismantle the parasites in an ordered fashion. Upon release from the mitochondrion, EndoG
translocates to the nucleus to degrade DNA. These events finally lead to the execution of
apoptosis [168]. Trypanosoma brucei causes neuronal demyelination and apoptosis after blood-
brain barrier damage. This leads to apoptosis in cells of the cerebellum and brain stem.
Welburn et al. [170] described cytoplasmic vacuolization and marginalization, extensive
membrane blebbing, and condensation of nuclear chromatin in Trypanosoma cruzi and T.
brucei respectively. Lectins such as ConA were among the first compounds shown to induce
the expression of apoptotic markers in T. brucei [169]. T. cruzi is the etiological agent of Chagas
disease. It also inhibits apoptosis through the action of parasite-derived neurotrophic factor,
a parasite-derived protein in neuronal and glial cells. The parasite-derived neurotrophic factor
is both a substrate and an activator of the serine-threonine kinase Akt and an antiapoptotic
molecule binding to the neurotrophic surface receptor TrkA (neurotrophic tyrosine kinase




This results in protection of Schwann cells from apoptosis induced by H2O2 and TNF-α/TGF-
β (transforming growth factor b) [170-172].
8.4. Leishmania
Leishmanias are agents of ulcerative skin lesions (cutaneous leishmaniasis) and disseminated
visceral infection (visceral leishmaniasis or kala-azar). Leishmania is able to inhibit the
spontaneous apoptosis of short-lived neutrophils, increasing their life span and providing a
safe place for the parasites during the first days of the infection [173]. With most apoptosis
inducing stimuli, Leishmania donovani shows typical features of apoptotic death like cell
shrinkage, nuclear condensation, and DNA fragmentation. Ca2+ appears to be a vital ion
involved in Leishmania apoptosis. Extracellular or intracellular Ca2+ during oxidative stress
results in the significant rescue of the fall of the mitochondrial membrane potential and
consequently apoptosis [174].
9. Concluding remarks
• Apoptosis is a genetically programmed process of cellular destruction that is indispensable
for the normal development and homeostasis of multicellular organisms.
• Microorganisms induce apoptosis by intrinsic and extrinsic pathway in the host cell.
• T3SS effectors have also been shown to tamper with the host’s cell cycle, and some of them
are able to induce apoptosis bacteria such as Pseudomonas, Shigella, Salmonella, and Yersinia.
• Microorganisms inhibit apoptosis by multiple mechanisms: protection of the mitochondria
and prevention of cytochrome c release (i.e., Chylamidia sp. and/or Neisseria sp.), activation
of cell survival pathways (i.e., Salmonella sp. and/or Rickettsia sp.), inhibition of caspases,
activation of phosphoinositide 3-kinase (PI3K)-Akt/protein kinase B (PKB) pathway, and
interaction with cellular caspases (i.e., Shigella sp. and/or Legionella sp.)
• Prevention of apoptosis enables microorganisms to replicate and survive in host.
• A clear understanding of the molecular basis of apoptosis inhibition or induction is needed.
• Elucidation of the mechanisms, the cellular receptors, and/or the microbial factors involved
in modulating of apoptosis could reveal insights into the host-pathogen relationship and
new therapeutic targets.
10. Abbreviations
AIF: apoptosis inducing factor
AP-1: activator protein 1
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BH: Bcl-2 homology
CARD: caspase activation and recruitment domain
CMV: cytomegalovirus
CTL: cytotoxic T lymphocyte
DD: death domains
DED: death effector domain
∆Ψm: transmembrane potential
EBV: Epstein-Barr virus
FADD: Fas-associated death domain
GSK-3: Glycogen synthase kinase 3
JNK: c-Jun N-terminal kinase
HIV-1: human immunodeficiency virus type 1
IAPs: inhibitors of apoptosis proteins
IL-1β: interleukin 1β
ICE: IL-1β converting enzyme
I-КB: inhibitor of КB
IKK: I-КB kinase
IPA: invasion plasmid antigens
LlyO: listeriolysin O
MOMP: mitochondrial outer membrane permeabilization
NF-κB: nuclear factor-kappa B
TLR: toll-like receptors
TNF: tumor necrosis factor
TNFR: tumor necrosis factor receptor gene
TRAIL: tumor necrosis factor (TNF)-related apoptosis-inducing ligand
T3SS : type III secretion system
PI3K: phosphoinositide 3-kinase







ROS: reactive oxygen species
RV: Rabies virus
SAPK: stress-activated protein kinase
STS: staurosporine
VDAC: voltage-dependent anionic channel
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